Vaccine Manufacturing Hub Will Help UK Meet Coronavirus Challenge
Will Work With Oxford And AstraZeneca On Fast-Tracked Candidate
Vaccine manufacturing capacity has been lost in the UK in recent decades. Now a new Vaccines Manufacturing Innovation Centre will re-seed that capacity and expertise - and the pandemic is accelerating its arrival.
You may also be interested in...
After setting up a sales base in the UK, Serum Institute could consider an acquisition in Europe or investment in an Oxford facility as it ties up production for its multiple COVID-19 vaccines. Is Wockhardt’s Wrexham facility an option?
With the Janssen and Novavax deals, the UK has now secured access to six different candidates across four different vaccine types.
Inovio vaccine data published, US government invests to protect, generic remdesivir launched in Bangladesh.